Max Essex | Academic Influence

Max Essex's AcademicInfluence.com Rankings

Max Essex

Biology

#1607

World Rank

#2645

Historical Rank

#781

USA Rank

Virology

#56

World Rank

#58

Historical Rank

#22

USA Rank

biology Degrees

Download Badge

Biology

Max Essex's Degrees

PhD Virology University of California, Berkeley
Doctorate Medicine University of California, San Francisco

Why Is Max Essex Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Myron Elmer "Max" Essex is the Mary Woodard Lasker Professor of Health Sciences, emeritus in the department of immunology and infectious diseases at Harvard University, chair of the Harvard T.H. Chan School of Public Health AIDS Initiative in the department of immunology and infectious diseases, and chair of the Botswana–Harvard AIDS Institute in Gaborone, Botswana. Essex was one of the first to link animal and human retroviruses to immunosuppressive disease, to suspect that a retrovirus was the cause of AIDS, and to determine that HIV could be transmitted through blood and blood products to hemophiliacs and recipients of blood transfusions. With collaborators, Essex also provided the first evidence that HIV could be transmitted by heterosexual intercourse.

(See a Problem?)

Max Essex's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Prevention of HIV-1 infection with early antiretroviral therapy. (2011) (2213)
Antiretroviral Therapy for the Prevention of HIV-1 Transmission. (2016) (1154)
Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. (1985) (946)
Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. (1985) (556)
Barriers to Antiretroviral Adherence for Patients Living with HIV Infection and AIDS in Botswana (2003) (543)
Antiretroviral regimens in pregnancy and breast-feeding in Botswana. (2010) (513)
A randomized trial of multivitamin supplements and HIV disease progression and mortality. (2004) (473)
Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. (2006) (461)
A high-density admixture map for disease gene discovery in african americans. (2004) (450)
Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. (2014) (445)
Response to antiretroviral therapy after a single, peripartum dose of nevirapine. (2007) (429)
Human immunodeficiency virus type 1 subtypes differ in disease progression. (1999) (410)
Slower heterosexual spread of HIV-2 than HIV-1 (1994) (380)
Neutralizing Antibodies to Adenovirus Serotype 5 Vaccine Vectors Are Directed Primarily against the Adenovirus Hexon Protein1 (2005) (376)
HIV-1 Langerhans' Cell Tropism Associated with Heterosexual Transmission of HIV (1996) (366)
Antibodies to cell membrane antigens associated with human T-cell leukemia virus in patients with AIDS. (1983) (336)
Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA (1986) (335)
The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions (1992) (330)
A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. (2000) (320)
Estimating the lost benefits of antiretroviral drug use in South Africa. (2008) (313)
Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana. (2012) (296)
SEROLOGICAL EVIDENCE FOR VIRUS RELATED TO SIMIAN T-LYMPHOTROPIC RETROVIRUS III IN RESIDENTS OF WEST AFRICA (1985) (293)
Horizontal Transmission of Feline Leukaemia Virus (1973) (275)
Serologic identification and characterization of a macaque T-lymphotropic retrovirus closely related to HTLV-III. (1985) (259)
Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. (2010) (257)
Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2. (1999) (255)
Mutations in the N-terminal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the Gag precursor (1993) (247)
Biology of feline leukemia virus in the natural environment. (1976) (247)
Randomized trial of vitamin supplements in relation to transmission of HIV-1 through breastfeeding and early child mortality (2002) (242)
HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture (2006) (240)
Neural-Tube Defects and Antiretroviral Treatment Regimens in Botswana. (2019) (232)
Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients. (1985) (231)
HTLV-III IN SYMPTOM-FREE SERONEGATIVE PERSONS (1984) (224)
Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype. (2006) (201)
A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients. (1985) (200)
Botswana's progress toward achieving the 2020 UNAIDS 90-90-90 antiretroviral therapy and virological suppression goals: a population-based survey. (2016) (192)
Isolation of T-lymphotropic retrovirus related to HTLV-III/LAV from wild-caught African green monkeys. (1985) (190)
Estimating the Impact of Plasma HIV-1 RNA Reductions on Heterosexual HIV-1 Transmission Risk (2010) (189)
Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy. (2011) (188)
Proposal for Naming Host Cell-Derived Inserts in Retrovirus Genomes (1981) (183)
Viruses in naturally occurring cancers (1980) (174)
Five-year outcomes of initial patients treated in Botswana's National Antiretroviral Treatment Program (2008) (174)
Antigens encoded by the 3'-terminal region of human T-cell leukemia virus: evidence for a functional gene. (1984) (172)
Male circumcision: an acceptable strategy for HIV prevention in Botswana (2003) (172)
Human Immunodeficiency Virus Type 1 Subtype C Molecular Phylogeny: Consensus Sequence for an AIDS Vaccine Design? (2002) (172)
Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by gag/env heteroduplex mobility assay. Study Group on Heterogeneity of HIV Epidemics in African Cities. (2000) (171)
Aetiology of AIDS—antibodies to human T-cell leukaemia virus (type III) in haemophiliacs (1984) (170)
EVIDENCE FOR HUMAN INFECTION WITH AN HTLV III/LAV-LIKE VIRUS IN CENTRAL AFRICA, 1959 (1986) (168)
Low Plasma Human Immunodeficiency Virus Type 2 Viral Load Is Independent of Proviral Load: Low Virus Production In Vivo (2000) (168)
Net survival of perinatally and postnatally HIV-infected children: a pooled analysis of individual data from sub-Saharan Africa. (2011) (167)
Association between Virus-Specific T-Cell Responses and Plasma Viral Load in Human Immunodeficiency Virus Type 1 Subtype C Infection (2003) (163)
Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein. (1986) (161)
Hepatitis B virus infection in cultured human lymphoblastoid cells. (1983) (161)
Horizontal transmission of leukemia virus and leukemia in the cat. (1973) (160)
Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes (1997) (160)
Association of feline leukemia virus with lymphosarcoma and other disorders in the cat. (1975) (155)
Preferential in-utero transmission of HIV-1 subtype C as compared to HIV-1 subtype A or D (2004) (153)
Infant morbidity, mortality, and breast milk immunologic profiles among breast-feeding HIV-infected and HIV-uninfected women in Botswana. (2007) (152)
Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of Env proteins into mature virions (1993) (149)
Trial of Shortened Zidovudine Regimens to Prevent Mother-to-Child Transmission of Human Immunodeficiency Virus Type 1 (2001) (145)
Universal Testing, Expanded Treatment, and Incidence of HIV Infection in Botswana. (2019) (142)
Lymphoma in macaques: association with virus of human T lymphotrophic family. (1984) (139)
Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial (2010) (138)
Initial Response to Highly Active Antiretroviral Therapy in HIV-1C-Infected Adults in a Public Sector Treatment Program in Botswana (2005) (137)
Horizontally and vertically transmitted oncornaviruses of cats. (1975) (134)
Human immunodeficiency virus vpr gene encodes a virion-associated protein. (1990) (134)
Molecular Cloning and Phylogenetic Analysis of Human Immunodeficiency Virus Type 1 Subtype C: a Set of 23 Full-Length Clones from Botswana (1999) (133)
Comparative Safety of Antiretroviral Treatment Regimens in Pregnancy (2017) (133)
Antibody to human T-lymphotropic virus type III in wives of hemophiliacs. Evidence for heterosexual transmission. (1985) (133)
Transmission of HIV‐1 Through Breastfeeding Among Women in Dar es Salaam, Tanzania (2002) (132)
A new HTLV-III/LAV protein encoded by a gene found in cytopathic retroviruses. (1986) (130)
Transmission of Cell-Free and Cell-Associated HIV-1 Through Breast-Feeding (2006) (128)
High Prevalence of the K65R Mutation in Human Immunodeficiency Virus Type 1 Subtype C Isolates from Infected Patients in Botswana Treated with Didanosine-Based Regimens (2006) (125)
Magnitude and Frequency of Cytotoxic T-Lymphocyte Responses: Identification of Immunodominant Regions of Human Immunodeficiency Virus Type 1 Subtype C (2002) (122)
Suppression of tuberculin skin reaction in healthy HTLV‐I carriers from Japan (1988) (122)
Identification of Human Immunodeficiency Virus Type 1 Subtype C Gag-, Tat-, Rev-, and Nef-Specific Elispot-Based Cytotoxic T-Lymphocyte Responses for AIDS Vaccine Design (2001) (121)
Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: an observational study (2018) (118)
Children Who Acquire HIV Infection Perinatally Are at Higher Risk of Early Death than Those Acquiring Infection through Breastmilk: A Meta-Analysis (2012) (117)
The vpx gene of simian immunodeficiency virus facilitates efficient viral replication in fresh lymphocytes and macrophage (1991) (115)
Suppression of the humoral antibody response in natural retrovirus infections. (1983) (115)
Correlation between Humoral Antibody and Regression of Tumours induced by Feline Sarcoma Virus (1971) (115)
Human immunodeficiency viruses in the developing world. (1999) (115)
Antiretroviral concentrations in breast-feeding infants of women in Botswana receiving antiretroviral treatment. (2005) (115)
Effect of micronutrient supplementation on disease progression in asymptomatic, antiretroviral-naive, HIV-infected adults in Botswana: a randomized clinical trial. (2013) (114)
Polymerase chain reaction analysis of defective human T-cell leukemia virus type I proviral genomes in leukemic cells of patients with adult T-cell leukemia (1991) (114)
A naturally immunogenic virion-associated protein specific for HIV-2 and SIV (1988) (113)
ANTIBODIES TO SIMIAN T-LYMPHOTROPIC RETROVIRUS TYPE III IN AFRICAN GREEN MONKEYS AND RECOGNITION OF STLV-III VIRAL PROTEINS BY AIDS AND RELATED SERA (1985) (111)
Randomized Trial of Vitamin Supplements in Relation to Vertical Transmission of HIV‐1 in Tanzania (2000) (109)
Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana (2006) (107)
HIV‐1 Epidemic Among Female Bar And Hotel Workers in Northern Tanzania: Risk Factors and Opportunities for Prevention (2002) (107)
Differences in perinatal transmission among human immunodeficiency virus type 1 genotypes. (2001) (106)
Antibodies to human T-cell leukemia virus membrane antigens (HTLV-MA) in hemophiliacs. (1983) (104)
Subcellular localization of the product of the long open reading frame of human T-cell leukemia virus type I. (1985) (104)
Excretion of feline leukaemia virus by naturally infected pet cats (1977) (103)
Highly active antiretroviral therapy started during pregnancy or postpartum suppresses HIV-1 RNA, but not DNA, in breast milk. (2005) (101)
Feline oncornavirus-associated cell membrane antigen: evidence for an immunologically crossreactive feline sarcoma virus-coded protein. (1977) (101)
Nonrandom distribution of gp120 N-linked glycosylation sites important for infectivity of human immunodeficiency virus type 1. (1992) (100)
Antibody to feline oncornavirus‐associated cell membrane antigen in neonatal cats (1971) (100)
Reduced Viral Replication Capacity of Human Immunodeficiency Virus Type 1 Subtype C Caused by Cytotoxic-T-Lymphocyte Escape Mutations in HLA-B57 Epitopes of Capsid Protein (2008) (99)
Statistical interpretation of the RV144 HIV vaccine efficacy trial in Thailand: a case study for statistical issues in efficacy trials. (2011) (97)
Open reading frame vpr of simian immunodeficiency virus encodes a virion-associated protein (1990) (96)
The C terminus of human immunodeficiency virus type 1 matrix protein is involved in early steps of the virus life cycle (1992) (95)
Impact of HLA-driven HIV adaptation on virulence in populations of high HIV seroprevalence (2014) (94)
Immunosurveillance of naturally occurring feline leukemia (1975) (93)
HTLV-I AND TROPICAL SPASTIC PARAPARESIS IN AFRICA (1986) (92)
Construction and Analysis of an Infectious Human Immunodeficiency Virus Type 1 Subtype C Molecular Clone (2001) (92)
Characteristics of HIV-1 Discordant Couples Enrolled in a Trial of HSV-2 Suppression to Reduce HIV-1 Transmission: The Partners Study (2009) (92)
Predictors of intrauterine and intrapartum transmission of HIV-1 among Tanzanian women (2001) (91)
Antibodies to human T-lymphotropic virus type III (HTLV-III) in saliva of acquired immunodeficiency syndrome (AIDS) patients and in persons at risk for AIDS. (1986) (90)
Epidemic expansion of HIV type 1 subtype C and recombinant genotypes in Tanzania. (1998) (89)
Elevated male European and female African contributions to the genomes of African American individuals (2006) (89)
Human T-cell leukemia virus-associated membrane antigens: identity of the major antigens recognized after virus infection. (1984) (88)
Elevated Tumor Necrosis Factor—α Activation of Human Immunodeficiency Virus Type 1 Subtype C in Southern Africa Is Associated with an NF-κ B Enhancer Gain-of-Function (2000) (85)
Detection of human anti‐HTLV‐III antibodies by indirect immunofluorescence using fixed cells (1985) (84)
Evidence of extrachromosomal forms of hepatitis B viral DNA in a bone marrow culture obtained from a patient recently infected with hepatitis B virus. (1984) (84)
PREVALENCE OF HUMAN T-LYMPHOTROPIC RETROVIRUSES TYPE III (HIV) AND TYPE IV IN IVORY COAST (1987) (83)
Horizontal transmission of feline leukemia virus in cats. (1975) (82)
Reassuring Birth Outcomes With Tenofovir/Emtricitabine/Efavirenz Used for Prevention of Mother-to-Child Transmission of HIV in Botswana (2016) (82)
Pseudotypes of feline sarcoma virus contain an 85,000-dalton protein with feline oncornavirus-associated cell membrane antigen (FOCMA) activity. (1978) (81)
Higher-Than-Expected Rates of Lactic Acidosis Among Highly Active Antiretroviral Therapy-Treated Women in Botswana: Preliminary Results from a Large Randomized Clinical Trial (2007) (81)
The role of herpes simplex virus type 2 and other genital infections in the acquisition of HIV-1 among high-risk women in northern Tanzania. (2007) (80)
Development of virus non-producer lymphosarcomas in pet cats exposed to FeLV (1980) (78)
Low adherence to recommended infant feeding strategies among HIV-infected women: results from the pilot phase of a randomized trial to prevent mother-to-child transmission in Botswana. (2003) (78)
Dysregulation of interleukin‐7 receptor may generate loss of cytotoxic T cell response in human immunodeficiency virus type 1 infection (1994) (76)
Genomewide Association Study for Determinants of HIV-1 Acquisition and Viral Set Point in HIV-1 Serodiscordant Couples with Quantified Virus Exposure (2011) (76)
Cancer Incidence following Expansion of HIV Treatment in Botswana (2015) (75)
New human and simian HIV-related retroviruses possess functional transactivator (tat) gene (1987) (74)
The reverse transcriptase 67N 70R 215Y genotype is the predominant TAM pathway associated with virologic failure among HIV type 1C-infected adults treated with ZDV/ddI-containing HAART in southern Africa. (2007) (73)
CCR5 coreceptor utilization involves a highly conserved arginine residue of HIV type 1 gp120. (1998) (73)
Effects of in Utero Antiretroviral Exposure on Longitudinal Growth of HIV-Exposed Uninfected Infants in Botswana (2011) (73)
Human immunodeficiency virus type 1 has an additional coding sequence in the central region of the genome. (1988) (72)
Low sensitivity of ELISA testing in early HIV infection. (1986) (72)
Intrathecal synthesis of antibodies to human T lymphotropic virus type I and the presence of IgG oligoclonal bands in the cerebrospinal fluid of patients with endemic tropical spastic paraparesis. (1988) (70)
Noninfectious entry of HIV-1 into peripheral and brain macrophages mediated by the mannose receptor (2007) (70)
HIV-1 LTR subtype and perinatal transmission. (2001) (70)
A feline leukaemia virus- and sarcoma virus-induced tumour-specific antigen (1977) (69)
Naturally occurring persistent feline oncornavirus infections in the absence of disease (1975) (68)
SENSITIVITY OF HUMAN NATURAL KILLER CELLS TO HYPERTHERMIA (1982) (68)
Differential regulation of HIV-1 clade-specific B, C, and E long terminal repeats by NF-kappaB and the Tat transactivator. (2002) (67)
Safety and efficacy of nevirapine- and efavirenz-based antiretroviral treatment in adults treated for TB-HIV co-infection in Botswana. (2009) (67)
Dysregulation through the NF-κB Enhancer and TATA Box of the Human Immunodeficiency Virus Type 1 Subtype E Promoter (1998) (67)
Extended high viremics: a substantial fraction of individuals maintain high plasma viral RNA levels after acute HIV-1 subtype C infection (2011) (66)
Feline oncornavirus-associated cell membrane antigen: expression in transformed nonproducer mink cells. (1977) (66)
Infection with human immunodeficiency virus type 1 (HIV-1) and human T cell lymphotropic viruses among leprosy patients and contacts: correlation between HIV-1 cross-reactivity and antibodies to lipoarabinomannan. (1994) (66)
Perinatal transmission of hepatitis B virus in Senegal, west Africa. (1993) (65)
Molecular epidemiology of an HIV-1 subtype A subcluster among injection drug users in the Southern Ukraine. (1998) (64)
Secretory IgA antibodies to human immunodeficiency virus in the parotid saliva of patients with AIDS and AIDS-related complex. (1987) (61)
In-utero triple antiretroviral exposure associated with decreased growth among HIV-exposed uninfected infants in Botswana (2016) (60)
In vitro correlates of HIV-2-mediated HIV-1 protection. (2000) (60)
A new human immunodeficiency virus type 1 circulating recombinant form from Tanzania. (2001) (60)
ANTIBODIES TO HUMAN T CELL LEUKAEMIA VIRUS-ASSOCIATED MEMBRANE ANTIGENS IN HAEMOPHILIACS: EVIDENCE FOR INFECTION BEFORE 1980 (1983) (60)
Hypervariable region 3 residues of HIV type 1 gp120 involved in CCR5 coreceptor utilization: therapeutic and prophylactic implications. (1999) (60)
Response to Zidovudine/Didanosine-Containing Combination Antiretroviral Therapy Among HIV-1 Subtype C-Infected Adults in Botswana: Two-Year Outcomes from a Randomized Clinical Trial (2009) (59)
HIV‐1 and HIV‐2 dual infection: lack of HIV‐2 provirus correlates with low CD4+ lymphocyte counts (1998) (58)
Randomized trial of vitamin supplements in relation to vertical transmission of HIV-1 in Tanzania (2000) (58)
Point-of-Care Cepheid Xpert HIV-1 Viral Load Test in Rural African Communities Is Feasible and Reliable (2016) (58)
Influence of Gag-Protease-Mediated Replication Capacity on Disease Progression in Individuals Recently Infected with HIV-1 Subtype C (2011) (58)
The origins of the AIDS virus. (1988) (57)
Prevention of the contagious spread of feline leukaemia virus and the development of leukaemia in pet cats (1976) (57)
Hepatitis B virus core antigen (HBc Ag) accumulation in an HBV nonproducer clone of HepG2-transfected cells is associated with cytopathic effect. (1990) (57)
Pregnancy Rates and Birth Outcomes Among Women on Efavirenz-Containing Highly Active Antiretroviral Therapy in Botswana (2007) (57)
Salivary antibodies as a means of detecting human T cell lymphotropic virus type III/lymphadenopathy-associated virus infection (1986) (56)
Elevated tumor necrosis factor-alpha activation of human immunodeficiency virus type 1 subtype C in Southern Africa is associated with an NF-kappaB enhancer gain-of-function. (2000) (55)
Emerging recombinant human immunodeficiency viruses: uneven representation of the envelope V3 region. (1999) (55)
Antibodies to human immunodeficiency virus in cervical secretions from women at risk for AIDS. (1987) (55)
HIV-1 Subtype C-Infected Individuals Maintaining High Viral Load as Potential Targets for the “Test-and-Treat” Approach to Reduce HIV Transmission (2010) (54)
Antibody seronegative human T-lymphotropic virus type III (HTLV-III)-infected patients with acquired immunodeficiency syndrome or related disorders. (1985) (54)
Epidemic acquired immune deficiency syndrome: epidemiologic evidence for a transmissible agent. (1983) (54)
Mutational analysis of conserved N-linked glycosylation sites of human immunodeficiency virus type 1 gp41 (1992) (54)
Natural feline leukemia virus infection and the immune response of cats of different ages. (1980) (54)
Sexual transmission of human T-cell leukemia virus type I associated with the presence of anti-Tax antibody. (1991) (54)
Mutations in the V3 stem versus the V3 crown and C4 region have different effects on the binding and fusion steps of human immunodeficiency virus type 1 gp120 interaction with the CCR5 coreceptor. (2007) (53)
Transmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection (2011) (53)
Incorporation of HLA antigens into the envelope of RNA tumor viruses grown in human cells. (1979) (52)
Role of conserved gp41 cysteine residues in the processing of human immunodeficiency virus envelope precursor and viral infectivity (1991) (52)
Role of the C terminus Gag protein in human immunodeficiency virus type 1 virion assembly and maturation. (1995) (51)
Feline oncornavirus-associated cell-membrane antigen (FOCMA): distinction between FOCMA and the major virion glycoprotein. (1977) (51)
Influence of antisera to oncornavirus glycoprotein (gp71) on infections of cats with feline leukemia virus. (1978) (51)
Sequence of the envelope glycoprotein gene of type II human T lymphotropic virus. (1984) (51)
HIV-1 subtype C in vitro growth and coreceptor utilization. (2006) (51)
Increased Risk of Severe Infant Anemia After Exposure to Maternal HAART, Botswana (2011) (50)
Comparison of virus-positive and virus-negative cases of feline leukemia and lymphoma. (1979) (49)
Effect of Amino Acid Substitution of the V3 and Bridging Sheet Residues in Human Immunodeficiency Virus Type 1 Subtype C gp120 on CCR5 Utilization (2003) (49)
Low CD4+ T-Lymphocyte Values in Human Immunodeficiency Virus-Negative Adults in Botswana (2004) (49)
Viral Load and CD4+ T-Cell Dynamics in Primary HIV-1 Subtype C Infection (2009) (49)
Horizontal transmission of feline leukemia virus under natural conditions in a feline leukemia cluster household (1977) (49)
Infection of hematopoietic progenitor cells by HIV-1 subtype C, and its association with anemia in southern Africa. (2007) (48)
Antibody reactivity to different regions of human T-cell leukemia virus type 1 gp61 in infected people (1989) (48)
Molecular cloning and biological characterization of full-length HIV-1 subtype C from Botswana. (2000) (48)
Identification of the envelope V3 loop as a determinant of a CD4-negative neuronal cell tropism for HIV-1. (1996) (48)
HIV transmission and 24-month survival in a randomized trial of HAART to prevent MTCT during pregnancy and breastfeeding in Botswana (2013) (47)
Helminth infection suppresses T-cell immune response to HIV-DNA-based vaccine in mice. (2006) (46)
Efficacy of antiretroviral drugs in reducing mother-to-child transmission of HIV in Africa: a meta-analysis of published clinical trials. (2008) (46)
Identification of most frequent HLA class I antigen specificities in Botswana: relevance for HIV vaccine design. (2001) (45)
Nucleotide and Amino Acid Polymorphisms at Drug Resistance Sites in Non-B-Subtype Variants of Human Immunodeficiency Virus Type 1 (2004) (45)
HIV-2 link to AIDS in West Africa. (1990) (45)
Serological evidence of HIV-associated infection among HIV-1-infected adults in Botswana. (2006) (45)
Mother‐to-child transmission of HIV‐1 in Congo, central Africa (1994) (45)
HIV-1 Subtype C Drug-Resistance Background among ARV-Naive Adults in Botswana (2005) (45)
Interleukin 2-independent interleukin 7 activity enhances cytotoxic immune response of HIV-1-infected individuals. (1994) (44)
Recognition of Variant HIV-1 Epitopes from Diverse Viral Subtypes by Vaccine-Induced CTL1 (2004) (44)
AIDS Denialism and Public Health Practice (2010) (44)
Non-nucleoside reverse transcriptase inhibitor outcomes among combination antiretroviral therapy-treated adults in Botswana (2010) (44)
Maternal antibody response at delivery and perinatal transmission of human immunodeficiency virus type 1 in African women (1994) (43)
Analysis of anti‐tax antibody of HTLV‐I carriers in an endemic area in Japan (1993) (43)
Neurologic manifestations of AIDS: a comparative study of two populations from Mexico and the United States. (1995) (43)
Impact of sampling density on the extent of HIV clustering. (2014) (43)
Herpes Simplex Virus Type 2 Infection Among Bar and Hotel Workers in Northern Tanzania: Prevalence and Risk Factors (2003) (43)
Immunogenic nature of a Pol gene product of HTLV-III/LAV. (1987) (43)
Specificity of four laboratory approaches for cross-sectional HIV incidence determination: analysis of samples from adults with known nonrecent HIV infection from five African countries. (2012) (42)
Feline oncornavirus-associated cell membrane antigen. IV. Antibody titers in cats with naturally occurring leukemia, lymphoma, and other diseases. (1975) (42)
HIV-exposed children account for more than half of 24-month mortality in Botswana (2016) (42)
Transmission of human immunodeficiency type 1 viruses with intersubtype recombinant long terminal repeat sequences. (1999) (41)
Cell-surface antigens induced by RNA tumour viruses (1979) (41)
Predictors of herpes simplex virus type 2 prevalence and incidence among bar and hotel workers in Moshi, Tanzania. (2007) (41)
Quantifying HIV transmission flow between high-prevalence hotspots and surrounding communities: a population-based study in Rakai, Uganda (2020) (41)
Hematologic and hepatic toxicities associated with antenatal and postnatal exposure to maternal highly active antiretroviral therapy among infants (2008) (41)
Tax mutation associated with tropical spastic paraparesis/human T-cell leukemia virus type I-associated myelopathy (1995) (41)
Drug resistance profiles of recombinant reverse transcriptases from human immunodeficiency virus type 1 subtypes A/E, B, and C. (2003) (41)
Risk factors for very preterm delivery and delivery of very‐small‐for‐gestational‐age infants among HIV‐exposed and HIV‐unexposed infants in Botswana (2011) (41)
Use of a resin-bound synthetic peptide for identifying a neutralizing antigenic determinant associated with the human immunodeficiency virus envelope. (1987) (41)
Covariability of selected amino acid positions for HIV type 1 subtypes C and B. (2005) (41)
Human T-cell leukemia virus: its discovery and role in leukemogenesis and immunosuppression. (1984) (40)
Immune response to leukemia virus and tumor-associated antigens in cats. (1976) (39)
Minor resistant variants in nevirapine-exposed infants may predict virologic failure on nevirapine-containing ART. (2010) (39)
Increased Risk of Preterm Delivery Among HIV-Infected Women Randomized to Protease Versus Nucleoside Reverse Transcriptase Inhibitor–Based HAART During Pregnancy (2011) (39)
A virion-specific inhibitory molecule with therapeutic potential for human immunodeficiency virus type 1. (1993) (39)
Vpx of simian immunodeficiency virus is localized primarily outside the virus core in mature virions (1993) (39)
Envelope glycoprotein 120 sequences of primary HIV type 1 isolates from Pune and New Delhi, India. (1996) (39)
Immunocytochemical and electron microscopic study of hepatitis B virus antigen and complete particle production in hepatitis B virus DNA transfected HepG2 cells (1990) (39)
Persistently elevated serum interleukin-6 predicts mortality among adults receiving combination antiretroviral therapy in Botswana: results from a clinical trial. (2013) (39)
Evolution of proviral gp120 over the first year of HIV-1 subtype C infection. (2009) (39)
Nucleotide sequence analysis of a full‐length human T‐cell leukemia virus type I from adult T‐cell leukemia cells: A prematurely terminated PX open reading frame II (1995) (38)
Transfusion-acquired human immunodeficiency virus infection among immunocompromised persons. (1986) (38)
Comparative prediction of perinatal human immunodeficiency virus type 1 transmission, using multiple virus load markers. (2003) (37)
Using HIV viral load to guide treatment-for-prevention interventions. (2012) (37)
Feline oncornavirus-associated cell membrane antigen. I. Serologic studies with kittens exposed to cell-free materials from various feline fibrosarcomas. (1973) (37)
Risk of HIV-1 transmission by breastfeeding among mothers infected with recombinant and non-recombinant HIV-1 genotypes. (2006) (37)
Cross-reactivity to human T-lymphotropic virus type III/lymphadenopathy-associated virus and molecular cloning of simian T-cell lymphotropic virus type III from African green monkeys. (1986) (37)
Sample size considerations in the design of cluster randomized trials of combination HIV prevention (2014) (37)
A randomized, placebo-controlled trial of granulocyte-macrophage colony-stimulating factor and nucleoside analogue therapy in AIDS. (2000) (36)
Ultrasensitive detection of minor drug-resistant variants for HIV after nevirapine exposure using allele-specific PCR: clinical significance. (2010) (36)
Serological studies of normal and leukemic cats in a multiple-case leukemia cluster. (1974) (36)
Hypermutation of HIV type 1 genomes isolated from infants soon after vertical infection. (2003) (35)
Feline oncornavirus-associated cell membrane antigen. III. Antibody titers in cats from leukemia cluster households. (1975) (35)
Identification of primary HIV-1C infection in Botswana (2008) (35)
The N-terminal region of the human immunodeficiency virus envelope glycoprotein gp120 contains potential binding sites for CD4. (1990) (35)
Infectious Simian/Human Immunodeficiency Virus with Human Immunodeficiency Virus Type 1 Subtype C from an African Isolate: Rhesus Macaque Model (2001) (35)
Simplified Strategy for Detection of Recombinant Human Immunodeficiency Virus Type 1 Group M Isolates bygag/env Heteroduplex Mobility Assay (2000) (35)
A molecularly cloned hepatitis B virus produced in vitro is infectious in a chimpanzee (1988) (34)
Serological cross-reactivity between envelope gene products of type I and type II human T-cell leukemia virus. (1984) (34)
Unreported antiretroviral use by HIV-1-infected participants enrolling in a prospective research study. (2014) (34)
Noma in children with severe combined immunodeficiency. (1986) (34)
High HTLV‐I proviral DNA level associated with abnormal lymphocytes in peripheral blood from asymptomatic carriers (1992) (34)
Intra-host evolutionary rates in HIV-1C env and gag during primary infection. (2013) (34)
A fragment of anthrax lethal factor delivers proteins to the cytosol without requiring protective antigen (2003) (34)
Effect of co-trimoxazole on mortality in HIV-exposed but uninfected children in Botswana (the Mpepu Study): a double-blind, randomised, placebo-controlled trial. (2017) (34)
Molecular mimicry between the human immunodeficiency virus type 1 gp120 V3 loop and human brain proteins (1993) (33)
Type-specific antigens for serological discrimination of HTLV-I and HTLV-II infection (1990) (33)
High Viral Load and Elevated Angiogenic Markers Associated With Increased Risk of Preeclampsia Among Women Initiating Highly Active Antiretroviral Therapy in Pregnancy in the Mma Bana Study, Botswana (2013) (33)
Feline virus-induced tumors and the immune response: recent developments. (1973) (33)
Prevalence of human papillomavirus genotypes and associated cervical squamous intraepithelial lesions in HIV‐infected women in Botswana (2011) (33)
Impact of Human Immunodeficiency Virus Type 1 Subtype C on Drug Resistance Mutations in Patients from Botswana Failing a Nelfinavir-Containing Regimen (2006) (33)
Antigens of human T-lymphotropic virus type III/lymphadenopathy-associated virus. (1985) (33)
Relation between HIV-2 proviral load and CD4+ lymphocyte count differs in monotypic and dual HIV infections. (1999) (32)
Strengthening biostatistics resources in sub‐Saharan Africa: Research collaborations through U.S. partnerships (2011) (32)
Phylogenetic Relatedness of Circulating HIV-1C Variants in Mochudi, Botswana (2013) (32)
Feline leukemia virus: survival under home and laboratory conditions (1979) (32)
Genetic analysis of HIV type 2 in monotypic and dual HIV infections. (2000) (31)
Major Histocompatibility Complex Class II (HLA-DRB and -DQB) Allele Frequencies in Botswana: Association with Human Immunodeficiency Virus Type 1 Infection (2005) (31)
Seroepidemiology of human T-cell lymphotropic virus type I infection in Taiwan. (1988) (31)
Antibody response in cats to feline leukemia virus reverse transcriptase under natural conditions of exposure to the virus. (1978) (31)
Better Control of Early Viral Replication Is Associated With Slower Rate of Elicited Antiviral Antibodies in the Detuned Enzyme Immunoassay During Primary HIV-1C Infection (2009) (31)
Antibodies from healthy cats exposed to feline leukemia virus lyse feline lymphoma cells slowly with cat complement. (1977) (30)
Identifying Recent HIV Infections: From Serological Assays to Genomics (2015) (30)
Results of a Population-Based Survey (2016) (30)
The Future of HIV Prevention (2012) (30)
HIV-1 pol sequences from India fit distinct subtype pattern. (1996) (30)
Antibody to human T-cell leukemia virus membrane antigens, beta 2-microglobulin levels, and thymosin alpha 1 levels in hemophiliacs and their spouses. (1984) (29)
Human T cell leukemia virus type III antibody, lymphadenopathy, and acquired immune deficiency syndrome in hemophiliac subjects. Results of a prospective study. (1986) (29)
Timing Constraints of In Vivo Gag Mutations during Primary HIV-1 Subtype C Infection (2009) (29)
Prevalence of transmitted HIV drug resistance in Botswana: lessons learned from the HIVDR-Threshold Survey conducted among women presenting for routine antenatal care as part of the 2007 national sentinel survey. (2011) (29)
Feline oncornavirus-associated cell membrane antigen. II. Antibody titers in healthy cats from household and laboratory colony environments. (1975) (29)
The design and validation of a novel phenotypic assay to determine HIV-1 coreceptor usage of clinical isolates. (2010) (29)
Sharp increase in rates of HIV transmitted drug resistance at antenatal clinics in Botswana demonstrates the need for routine surveillance. (2016) (29)
Killing of primary CD4+ T cells by non-syncytium-inducing macrophage-tropic human immunodeficiency virus type 1. (1994) (29)
Antibody responses in early human immunodeficiency virus type 1 infection in hemophiliacs. (1988) (28)
Gene-expression profiling of HIV-1 infection and perinatal transmission in Botswana (2006) (28)
High Prevalence of Hypertension and Placental Insufficiency, but No In Utero HIV Transmission, among Women on HAART with Stillbirths in Botswana (2012) (28)
High Rates of Occult Hepatitis B Virus Infection in HIV-Positive Individuals Initiating Antiretroviral Therapy in Botswana (2017) (27)
Risk factors for early and late transmission of HIV via breast-feeding among infants born to HIV-infected women in a randomized clinical trial in Botswana. (2009) (27)
Antiretroviral Treatment Initiation Among HIV-Infected Pregnant Women with Low CD4+ Cell Counts in Gaborone, Botswana (2009) (27)
Diversity of the HIV-1 long terminal repeat following mother-to-child transmission. (2000) (27)
Delivery of exogenous protein antigens to major histocompatibility complex class I pathway in cytosol. (2002) (27)
In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes. (2003) (26)
Epidemiologic association between virus-negative feline leukemia and the horizontally transmitted feline leukemia virus. (1981) (26)
Using nearly full-genome HIV sequence data improves phylogeny reconstruction in a simulated epidemic (2016) (26)
Polymorphisms of cytotoxic T-lymphocyte (CTL) and T-helper epitopes within reverse transcriptase (RT) of HIV-1 subtype C from Ethiopia and Botswana following selection of antiretroviral drug resistance. (2002) (26)
Humoral immune responses of cats to feline leukemia virus: comparison of responses to the major structural protein p30 and to a virus-specific cell membrane antigen (FOCMA). (1976) (26)
Estimated age and gender profile of individuals missed by a home-based HIV testing and counselling campaign in a Botswana community (2015) (26)
Preferred nucleotide sequence at the integration target site of human T‐cell leukemia virus type I from patients with adult T‐cell leukemia (1996) (26)
Intrapatient variability of the human immunodeficiency virus type 2 envelope V3 loop. (1995) (25)
Slow CD4+ T-Cell Recovery in Human Immunodeficiency Virus/Hepatitis B Virus-Coinfected Patients Initiating Truvada-Based Combination Antiretroviral Therapy in Botswana (2016) (25)
Protection from HIV-1 infection by HIV-2. (1998) (25)
Dynamics and timing of in vivo mutations at Gag residue 242 during primary HIV-1 subtype C infection. (2010) (25)
Apparent transmission of human T-cell leukemia virus type III to a heterosexual woman with the acquired immunodeficiency syndrome. (1985) (25)
The prevalence of antibody to p42 of HTLV‐1 among ATLL patients in comparison with healthy carriers in Japan (1989) (25)
Molecular evolution of human immunodeficiency virus type 1 subtype A in Senegal: 1988-1997. (2000) (25)
Quantifying ongoing HIV-1 exposure in HIV-1-serodiscordant couples to identify individuals with potential host resistance to HIV-1. (2012) (25)
Replicative Fitness Costs of Nonnucleoside Reverse Transcriptase Inhibitor Drug Resistance Mutations on HIV Subtype C (2011) (25)
Glycolysis During Early Infection of Feline and Human Cells with Feline Leukemia Virus (1974) (25)
Mortality Among HIV-1-Infected Women According to Children's Feeding Modality: An Individual Patient Data Meta-Analysis (2005) (24)
Hepatitis B virus activation among central Africans infected with human immunodeficiency virus (HIV) type 1: pre-s2 antigen is predominantly expressed in HIV infection. (1994) (24)
Replicative Capacity Differences of Thymidine Analog Resistance Mutations in Subtype B and C Human Immunodeficiency Virus Type 1 (2009) (24)
Immunity to leukemia, lymphoma, and fibrosarcoma in cats: a case for immunosurveillance. (1977) (24)
INFECTION OF BONE MARROW CELLS BY HEPATITIS B VIRUS (1983) (24)
Adult combination antiretroviral therapy in sub-Saharan Africa: lessons from Botswana and future challenges. (2009) (24)
Transactivation is a conserved function among primate lentivirus Vpr proteins but is not shared by Vpx. (1999) (24)
HIV-1 Subtype C Phylodynamics in the Global Epidemic (2010) (24)
Improvement in allele-specific PCR assay with the use of polymorphism-specific primers for the analysis of minor variant drug resistance in HIV-1 subtype C. (2008) (24)
Contribution of Maternal Antiretroviral Therapy and Breastfeeding to 24-Month Survival in Human Immunodeficiency Virus-Exposed Uninfected Children: An Individual Pooled Analysis of African and Asian Studies (2017) (24)
Mutations and Polymorphisms Associated with Antiretroviral Drugs in HIV-1C-Infected African Patients (2004) (24)
Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering (2015) (24)
State of the HIV pandemic. (1998) (24)
Expression of virus‐associated antigens and immune cell functions during spontaneous regression of the friend viral murine leukemia (1975) (23)
High incidence of antibodies to HTLV-I tax in blood relatives of adult T cell leukemia patients. (1991) (23)
FeLV-induced feline acquired immune deficiency syndrome. A model for human AIDS. (1986) (23)
Voluntary counseling and testing among post-partum women in Botswana. (2007) (23)
HIV type 1 A/J recombinant with a pronounced pol gene mosaicism. (2000) (23)
Delineation of type-specific regions on the envelope glycoproteins of human T cell leukemia viruses. (1991) (23)
Env sequence determinants in CXCR4-using human immunodeficiency virus type-1 subtype C. (2012) (23)
Genetic characterization of viral quasispecies in blood and cervical secretions of HIV-1- and HIV-2-infected women. (1998) (23)
Single amino acid substitution in constant region 1 or 4 of gp120 causes the phenotype of a human immunodeficiency virus type 1 variant with mutations in hypervariable regions 1 and 2 to revert (1996) (23)
Animal model: feline acute lymphoblastic leukemia and aplastic anemia. (1977) (23)
Antibodies in normal and leukemic cats to feline oncornavirus-associated cell membrane antigens. (1973) (23)
Virological implications of the use of primates in xenotransplantation. (1987) (22)
HIV-1 Subtypes and Recombinants (2002) (22)
Inhibition of feline leukemia virus replication by human leukocyte interferon. (1983) (22)
HIV type 1 subtypes among bar and hotel workers in Moshi, Tanzania. (2003) (22)
Distinct quasi-species in the blood and the brain of an HIV-2-infected individual. (1996) (22)
Increased risk for lymphoma and glomerulonephritis in a closed population of cats exposed to feline leukemia virus. (1980) (22)
Feline leukemia: a naturally occurring cancer of infectious origin. (1982) (21)
Interactive association of proviral load and IFN-gamma-secreting T cell responses in HIV-1C infection. (2006) (21)
HIV-2 infection in the United States. (1989) (21)
Increased promoter diversity reveals a complex phylogeny of human immunodeficiency virus type 1 subtype C in India. (2000) (21)
Highly Active Antiretroviral Therapy Versus Zidovudine for Prevention of Mother-to-Child Transmission in a Programmatic Setting, Botswana (2011) (21)
Quantitation of human immunodeficiency virus type 1 viral load in plasma using reverse transcriptase activity assay at a district hospital laboratory in Botswana: a decentralization pilot study. (2009) (20)
Susceptibility of human cell lines to feline leukemia virus and feline sarcoma virus. (1979) (20)
HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies (2012) (20)
A seronegative case of HIV-1 subtype C infection in Botswana. (2007) (20)
Prevalence, Magnitude, and Correlates of HIV-1 Genital Shedding in Women on Antiretroviral Therapy (2017) (20)
Feline oncornavirus-associated cell membrane antigen. V. Humoral immune response to virus and cell membrane antigens in cats inoculated with Gardner-Arnstein feline sarcoma virus. (1975) (20)
Sexually transmitted diseases and risk of HIV infection in men attending a sexually transmitted diseases clinic in Dakar, Senegal. (1997) (20)
Interaction with human immunodeficiency virus (HIV) type 2 predicts HIV type 1 genotype. (2000) (20)
Toll-like receptor gene variants and bacterial vaginosis among HIV-1 infected and uninfected African women (2015) (20)
HIV-1 Full-Genome Phylogenetics of Generalized Epidemics in Sub-Saharan Africa: Impact of Missing Nucleotide Characters in Next-Generation Sequences (2017) (20)
Neutralization of feline leukemia virus with feline antisera to leukocyte alloantigens. (1982) (20)
Herpes simplex virus type 2 suppressive therapy with acyclovir or valacyclovir does not select for specific HIV-1 resistance in HIV-1/HSV-2 dually infected persons. (2011) (19)
Prevalence and Clinical Associations of CXCR4-Using HIV-1 Among Treatment-Naive Subtype C-Infected Women in Botswana (2011) (19)
Changes in the expression of HLA and beta 2-microglobulin by cultured lymphoid cells. (1982) (19)
The aetiology of diarrhoea, pneumonia and respiratory colonization of HIV-exposed infants randomized to breast- or formula-feeding (2016) (19)
Leukemia and lymphoma: infrequent manifestations of common viral infections? A review. (1978) (19)
Immunohaematological reference values for HIV-negative healthy adults in Botswana (2011) (19)
Induction of the feline oncornavirus associated cell membrane antigen in human cells. (1972) (19)
Chronic and Occult Hepatitis B Virus Infection in Pregnant Women in Botswana (2018) (19)
Localization of immunogenic domains in the human immunodeficiency virus type 2 envelope (1991) (19)
Characterization of a feline sarcoma virus-coded antigen (FOCMA-S) by radioimmunoassay. (1978) (18)
Viral Diversity and Diversification of Major Non-Structural Genes vif, vpr, vpu, tat exon 1 and rev exon 1 during Primary HIV-1 Subtype C Infection (2012) (18)
Frequent Intra-Subtype Recombination among HIV-1 Circulating in Tanzania (2013) (18)
Common genetic arrangements among human immunodeficiency virus type 1 subtype A and D recombinant genomes vertically transmitted in Tanzania. (2002) (18)
Human T cell leukemia virus type I (HTLV-I) molecular genotypes and disease outcome. (1996) (18)
WHO Working Group on Characterization of HIV-Related Retroviruses: criteria for characterization and proposal for a nomenclature system. (1987) (18)
Importance of Viral Sequence Length and Number of Variable and Informative Sites in Analysis of HIV Clustering. (2015) (18)
Cross-sectional estimates revealed high HIV incidence in Botswana rural communities in the era of successful ART scale-up in 2013-2015 (2018) (18)
The Origins of HIV‐1 and HTLV‐4/HIV‐2 (1987) (18)
Risk factors for symptomatic hyperlactatemia and lactic acidosis among combination antiretroviral therapy-treated adults in Botswana: results from a clinical trial. (2012) (18)
Cotrimoxazole prophylaxis was associated with enteric commensal bacterial resistance among HIV‐exposed infants in a randomized controlled trial, Botswana (2017) (18)
Lysis of feline lymphoma cells by complement-dependent antibodies in feline leukemia virus contact cats. Correlation of lysis and antibodies to feline oncornavirus-associated cell membrane antigen. (1978) (17)
Seroepidemiologic testing in man for evidence of antibodies to feline leukemia virus and bovine leukemia virus. (1975) (17)
T-tropic sequence of the V3 loop is critical for HIV-1 infection of CXCR4-positive colonic HT-29 epithelial cells. (2000) (17)
Identification of non-B human immunodeficiency virus type 1 subtypes in rural Georgia. (2001) (17)
Evaluation of the false recent classification rates of multiassay algorithms in estimating HIV type 1 subtype C incidence. (2014) (17)
Sarcoma virus-induced transformation specific antigen: presence of antibodies in cats that were naturally exposed to leukemia virus. (1979) (17)
Molecular characterisation of hepatitis B virus in HIV-1 subtype C infected patients in Botswana (2015) (17)
Risk factors for HIV-1 and HIV-2 infection in pregnant women in Dakar, Senegal. (1994) (17)
Humoral Immune Pressure Selects for HIV-1 CXC-chemokine Receptor 4-using Variants (2016) (17)
HIV-1 epidemic among female bar and hotel workers in northern Tanzania: risk factors and opportunities for prevention. (2002) (17)
Differential stability of the mRNA secondary structures in the frameshift site of various HIV type 1 viruses. (1999) (16)
Feline leukemia virus infections: the significance of chronic viremia. (1979) (16)
The effect of micronutrient supplementation on active TB incidence early in HIV infection in Botswana (2017) (16)
Update: HIV-2 infection--United States. (1989) (16)
Perceptions of couple HIV counseling and testing in Botswana: a stakeholder analysis. (2010) (16)
Antigens of Human T-Lymphotropic Virus Type III/Lymphadenopathy-Associated Virus (1986) (16)
Identification of HLA class I-associated amino acid polymorphisms in the HIV-1C proteome. (2007) (16)
Alpha-fetoprotein synthesis in human hepatocellular carcinoma: correlation with hepatitis B surface antigen expression. (1992) (16)
Phylodynamic analysis of HIV sub-epidemics in Mochudi, Botswana. (2015) (16)
Role of the CCR5 delta 32 allele in resistance to HIV-1 infection in west Africa. (1998) (16)
Evaluation of autoantibodies to brain proteins in patients with AIDS dementia complex. (1994) (16)
Simian immunodeficiency virus in people. (1994) (15)
Progress towards an HIV-1 subtype C vaccine. (2006) (15)
Comparison of immunofluorescence, particle agglutination, and enzyme immunoassays for detection of human T-cell leukemia virus type I antibody in African sera (1990) (15)
The molecular epidemiology of HIV type 1 of men in Mexico. (2001) (15)
Retroviruses associated with leukemia and ablative syndromes in animals and in human beings. (1985) (15)
Membrane antigens of murine leukaemia cells (1974) (15)
Retroviral vaccines: challenges for the developing world. (1996) (15)
Humoral immune response of asymptomatic cats naturally infected with feline leukemia virus (1986) (15)
The Development and Utility of a Clinical Algorithm to Predict Early HIV-1 Infection (2005) (14)
HIV-1 drug mutations in children from northern Tanzania (2014) (14)
Nucleotide sequences of human T-lymphotropic virus type I (HTLV-I) from a family cluster with tropical spastic paraparesis/HTLV-I-associated myelopathy. (1995) (14)
Feline oncornavirus-associated cell membrane antigen. VI. Cytotoxic antibody in cats exposed to feline leukemia virus. (1976) (14)
Effect of BMI and fat mass on HIV disease progression in HIV-infected, antiretroviral treatment-naïve adults in Botswana. (2016) (14)
Cotrimoxazole Prophylaxis and Risk of Severe Anemia or Severe Neutropenia in HAART-Exposed, HIV-Uninfected Infants (2013) (14)
Effects of HIV type 1 infection on hematopoiesis in Botswana. (2007) (14)
tat Exon 1 Exhibits Functional Diversity during HIV-1 Subtype C Primary Infection (2013) (14)
Population uptake of HIV testing, treatment, viral suppression, and male circumcision following a community-based intervention in Botswana (Ya Tsie/BCPP): a cluster-randomised trial. (2020) (14)
Simian T-lymphotropic viruses and related human viruses. (1988) (13)
Protection of cats against feline leukemia virus-positive and virus-negative tumors by complement-dependent antibody. (1980) (13)
Undisclosed antiretroviral drug use in Botswana: implication for national estimates (2018) (13)
Therapeutic Levels of Lopinavir in Late Pregnancy and Abacavir Passage into Breast Milk in the Mma Bana Study, Botswana (2013) (13)
Human T-lymphotropic virus type I (HTLV-I)-specific antibodies and cell-free RNA in crevicular fluid-rich saliva from patients with tropical spastic paraparesis/HTLV-I-associated myelopathy. (1995) (13)
Co-receptor usage and HIV-1 intra-clade C polymorphisms in the protease and reverse transcriptase genes of HIV-1 isolates from Ethiopia and Botswana. (2002) (13)
Uncommon gp120 cysteine residues found in primary HIV-1 isolates. (1995) (12)
Adult T-Cell Leukemia-Lymphoma: Role of a Human Retrovirus (1982) (12)
Antibody profile of early HTLV-I infection (1990) (12)
Interaction between HIV type 1 glycoprotein 120 and CXCR4 coreceptor involves a highly conserved arginine residue in hypervariable region 3. (2000) (12)
Sequence features downstream of the primer-binding site of HIV type 1 subtype E shared by subtype G and a subset of subtype A. (1999) (12)
High levels of anti-HIV-1 envelope antibodies in cerebrospinal fluid as compared to serum from patients with AIDS dementia complex. (1996) (12)
Infant Feeding Practices were not Associated with Breast Milk HIV-1 RNA Levels in a Randomized Clinical Trial in Botswana (2012) (12)
Identification of CRF10_CD viruses among bar and hotel workers in Moshi, Northern Tanzania. (2005) (12)
HIV-2 and Natural Protection Against HIV-1 Infection (1996) (12)
Genome-Wide Analyses Reveal Gene Influence on HIV Disease Progression and HIV-1C Acquisition in Southern Africa. (2017) (12)
Birth weight for gestational age norms for a large cohort of infants born to HIV-negative women in Botswana compared with norms for U.S.-born black infants (2011) (12)
Experimental anterior uveitis after subcutaneous injection of feline sarcoma virus. (1983) (12)
CHAPTER 18 – The Immune Response to Oncornavirus Infections (1974) (12)
Complement and tumor antibody levels in cats, and changes associated with natural feline leukemia virus infection and malignant disease. (1979) (12)
Leukemia specific antigens: FOCMA and immune surveillance. (1979) (12)
Molecular characterization of hepatitis B virus in blood donors in Botswana (2018) (12)
Saturday Is for Funerals (2010) (12)
The highly conserved aspartic acid residue between hypervariable regions 1 and 2 of human immunodeficiency virus type 1 gp120 is important for early stages of virus replication (1995) (12)
Antibodies to human T-cell leukemia virus type III in hemophiliacs from Spain. (1985) (12)
Distribution of feline leukemia virus DNA sequences in tissues of normal and leukemic domestic cats. (1979) (11)
Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana (2018) (11)
Feline leukemia virus and hepatitis B virus: a comparison of late manifestations. (1981) (11)
Site-directed serology using synthetic oligopeptides representing the C-terminus of the external glycoproteins of HIV-1, HIV-2, or SIVmac may distinguish subtypes among primate lentiviruses. (1991) (11)
A STLV-III related human retrovirus, HTLV-IV: analysis of cross-reactivity with the human immunodeficiency virus (HIV). (1987) (11)
Characterization of clones of tumorigenic feline cells transformed by a chemical carcinogen (1981) (11)
Human T-cell leukemia/lymphoma virus : the family of human T-lymphotropic retroviruses, their role in malignancies and association with AIDS (1984) (11)
Genetic variation within human immunodeficiency viruses generates rapid changes in tropism, virulence, and transmission. (1997) (11)
Association of immune activation with intravenous heroin use and methadone treatment in HIV-1 seropositive and seronegative subjects. (1993) (11)
Retrovirus-encoded transformation-specific polyproteins: expression coordinated with malignant phenotype in cells from different germ layers. (1981) (11)
The Impact of Human Pegivirus on CD4 Cell Count in HIV-Positive Persons in Botswana (2017) (11)
Isolation and characterization of proteins carrying the feline oncornavirus-associated cell-membrane antigen. (1980) (11)
Can feline oncornaviruses cause leukemia in man? (1972) (10)
Interactions of murine leukemia virus (MuLV) with isolated lymphocytes. III. Alterations of splenic B and T cells in friend virus‐infected mice (1976) (10)
Natural killer activity against retrovirus infected cells: dichotomy in NK sensitivity of infected T and B cells. (1982) (10)
Reaching 90-90-90 in Botswana. (2019) (10)
HTLV and immunosuppression. (1984) (10)
Validation of A Point-of-Care Lactate Device For Screening At-Risk Adults Receiving Combination Antiretroviral Therapy In Botswana. (2011) (10)
Ecologic studies of Venezuelan encephalitis virus in southeastern Mexico. VI. Infection of wild birds. (1972) (10)
Daily Acyclovir Delays HIV-1 Disease Progression Among HIV-1/HSV-2 Dually-Infected Persons: A Randomized Trial (2010) (10)
Five-year follow up of genotypic resistance patterns in HIV-1 subtype C infected patients in Botswana after failure of thymidine analogue-based regimens (2009) (10)
High Proportion of Deaths Attributable to HIV Among Postpartum Women in Botswana Despite Widespread Uptake of Antiretroviral Therapy (2017) (10)
Prognostic Value of HIV-1 RNA on CD4 Trajectories and Disease Progression Among Antiretroviral-Naive HIV-Infected Adults in Botswana: A Joint Modeling Analysis. (2016) (10)
Molecular Characterization of Near Full-Length Genomes of Hepatitis B Virus Isolated from Predominantly HIV Infected Individuals in Botswana (2018) (10)
Response: HIV-2 and Natural Protection Against HIV-1 Infection. (1996) (10)
Serum antibodies against feline oncornavirus-associated cell membrane antigen in cats bearing virally induced uveal melanomas. (1981) (10)
Cell culture density modulates the incorporation of HLA antigens by enveloped viruses. (1983) (10)
Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages (2016) (10)
Comparison of simian immunodeficiency virus isolates (1988) (10)
Continuous Long-Term Replication of Feline Leukemia Virus (FeLV) in an Established Canine Cell Culture (MDCK) 1 (1972) (9)
Analysis of Viral Diversity in Relation to the Recency of HIV-1C Infection in Botswana (2016) (9)
Humanimmunodeficiency virus type1hasanadditional coding sequence inthecentral region ofthegenome (1988) (9)
Intra- and Intersubtype Alternative Pak2-Activating Structural Motifs of Human Immunodeficiency Virus Type 1 Nef (2006) (9)
HIV transmission in a dialysis center--Colombia, 1991-1993. (1995) (9)
Mother-to-child transmission of HIV-1 in Congo, central Africa. Congolese Research Group on Mother-to-Child Transmission of HIV. (1994) (9)
Effect of Gestational Age at Tenofovir-Emtricitabine-Efavirenz Initiation on Adverse Birth Outcomes in Botswana (2018) (9)
Antibodies to the HIV type 2 core protein p26 and Vpx: association with disease progression. (1998) (9)
Contribution of hypervariable domains to the conformation of a broadly neutralizing glycoprotein 120 epitope. (1995) (9)
Epidemiology and Transmission of HIV-2 in Senegal (1990) (8)
Lack of Virological Suppression Among Young HIV-Positive Adults in Botswana (2018) (8)
Influence of deletions in N or C terminus of HIV-1 glycoprotein 120 on binding of infectivity-enhancing antibody. (1994) (8)
Humoral aspects of anti-HIV immune responses in Zairians with AIDS: lower antigenemia does not correlate with immune complex levels. (1993) (8)
Relationship between humoral antibodies and the failure to develop progressive tumors in cats injected with feline sarcoma virus (FSV). (1973) (8)
Significance of the feline oncornavirus-associated cell-membrane antigen (FOCMA) in the natural history of feline leukemia. (1980) (8)
Mapping of HIV-1C Transmission Networks Reveals Extensive Spread of Viral Lineages across Villages in Botswana Treatment-as-Prevention Trial. (2020) (8)
Phylogenetic Inference of HIV Transmission Clusters (2017) (8)
Hepatitis B virus, alpha-fetoprotein synthesis, and hepatocellular carcinoma in Zaire. (2008) (8)
Temporal reduction of HIV type 1 viral load in breast milk by single-dose nevirapine during prevention of MTCT. (2009) (8)
Antibodies to HTLV-1 in saliva of seropositive individuals from Japan. (1987) (8)
Viruses in naturally occurring cancers. Book A, Book B. (1980) (8)
Viruses in naturally occurring cancers : abstracts of papers presented at the Seventh Cold Spring Harbor Conference on Cell Proliferation, September 4-September 9, 1979 (1979) (7)
Intrafamilial transmission of HTLV‐I and its association with anti‐Tax antibody in an endemic population in Japan (1998) (7)
Regional Variations in the African Epidemics (2002) (7)
Immunohaematological reference values for HIV-negative healthy adults in Botswana (2012) (7)
Pattern of gp120 sequence divergence linked to a lack of clinical progression in human immunodeficiency virus type 1 infection. (1996) (7)
HIV-1 subtype B in Honduras. (1999) (7)
Correction: Cancer Incidence following Expansion of HIV Treatment in Botswana (2015) (7)
Feline sarcoma virus-specific transformation-related proteins and protein kinase activity in tumor cells. (1983) (7)
Human GLI-2 Is a Tat Activation Response Element-Independent Tat Cofactor (2001) (7)
Association of CYP2B6 Genetic Variation with Efavirenz and Nevirapine Drug Resistance in HIV-1 Patients from Botswana (2021) (7)
Immune response of healthy and leukemic cats to the feline oncornavirus-associated cell membrane antigen. (1975) (7)
PANDAA-monium: Intentional violations of conventional qPCR design enables rapid, HIV-1 subtype-independent drug resistance SNP detection (2019) (7)
Feline Leukemia/Sarcoma Viruses and Immunodeficiency (1988) (7)
A comparison of the pathobiology and epidemiology of cancers associated with viruses in humans and animals. (1981) (7)
Prevalence of Rilpivirine and Etravirine Resistance Mutations in HIV-1 Subtype C-Infected Patients Failing Nevirapine or Efavirenz-Based Combination Antiretroviral Therapy in Botswana. (2018) (7)
Immunopathogenesis of HTLV. (1992) (6)
The Biology of HIV-1 and HIV-2 in Africa (1988) (6)
Antiretroviral prevention of HIV perinatal transmission (1994) (6)
Endogenous RD-114 Virus of Cats: Absence of Antibodies to RD-114 Envelope Antigens in Cats Naturally Exposed to Feline Leukemia Virus (1979) (6)
HIV-1 pol Diversity among Female Bar and Hotel Workers in Northern Tanzania (2014) (6)
AZT trial in Thailand. (1995) (6)
Transmitted/Founder HIV-1 Subtype C Viruses Show Distinctive Signature Patterns in Vif, Vpr, and Vpu That Are Under Subsequent Immune Pressure During Early Infection. (2016) (6)
Evolutionary gamut of in vivo Gag substitutions during early HIV-1 subtype C infection. (2011) (6)
Sequential change of cysteine residues in hypervariable region 1 of glycoprotein 120 in primary HIV type 1 isolates of subtype B. (1996) (6)
Vitamin D Insufficiency in HIV-infected Pregnant Women Receiving Antiretroviral Therapy is Not Associated With Morbidity, Mortality or Growth Impairment in Their Uninfected Infants in Botswana (2014) (6)
No Clinically Significant Drug-Resistance Mutations in HIV-1 Subtype C–Infected Women After Discontinuation of NRTI-Based or PI-Based HAART for PMTCT in Botswana (2013) (6)
Hepatitis delta virus antibodies in hepatitis B surface antigen asymptomatic carriers in Senegal. (1990) (6)
Antibodies to human T-cell leukemia virus-membrane antigens in macaques with malignant lymphoma. (1985) (6)
Lack of endemic HIV infection in Venezuela. (1987) (6)
Abacavir alters the transcription of inflammatory cytokines in virologically suppressed, HIV-infected women (2012) (6)
Epidemiology of HIV-1 infection in rural Georgia: demographic trends and analysis at the Medical College of Georgia. (1997) (6)
In Silico Analysis of Hepatitis B Virus Occult Associated Mutations in Botswana Using a Novel Algorithm (2018) (5)
On Weinstein's "Patient attitudes toward mental hospitalization: a review of quantitative research". (1980) (5)
Low rates of nucleoside reverse transcriptase inhibitor and nonnucleoside reverse transcriptase inhibitor drug resistance in Botswana (2019) (5)
Isotypic distribution of HIV-1-specific antibodies in individuals from central Africa. (1992) (5)
Estimating the prevalence of transmitted HIV drug resistance using pooled samples (2016) (5)
Non-Nucleoside Reverse Transcriptase Inhibitor Outcomes Among cART-Treated Adults in Botswana (2011) (5)
8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19–22 July 2015, Vancouver, Canada (2015) (5)
The Effect of a Single Nucleotide Substitution in the Splicing Silencer in the tat/rev Intron on HIV Type 1 Envelope Expression. (2006) (5)
An electron-lucent region within the virion distinguishes HIV-1 from HIV-2 and simian immunodeficiency virus. (1994) (5)
Immune Activation Markers in Peripartum Women in Botswana: Association with Feeding Strategy and Maternal Morbidity (2014) (5)
SEROEPIDEMIOLOGY OF HUMAN T‐CELL LEUKEMIA VIRUS IN THE FRENCH WEST INDIES: ANTIBODIES IN BLOOD DONORS AND PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES WHO DO NOT HAVE AIDS (1984) (5)
Increased CXCR4 use of HIV-1 subtype C identified by population sequencing in patients failing antiretroviral treatment compared with treatment-naive patients in Botswana. (2014) (5)
Letter to the editor of the NEJM (1998) (5)
Predictors of early breastfeeding cessation among HIV‐infected women in Botswana (2016) (5)
Short Communication: Low False Recent Rate of Limiting Antigen-Avidity Assay Combined with HIV-1 RNA Data in Botswana. (2016) (5)
HTLV AND AIDS IN FRANCE (1984) (5)
Transformation of feline embryo cells in culture by a chemical carcinogen (1979) (4)
Xenograft Transplantation and the Infectious Disease Conundrum (1995) (4)
Low rates of NRTI and NNRTI drug resistance among participants in the Botswana combination prevention program (BCPP) trial. (2019) (4)
Strategies of research for a vaccine against AIDS. (1995) (4)
Identification of a recombinant HTLV-II envelope protein for serological detection of HTLV-II carriers. (1991) (4)
Risk factors for mortality among human immunodeficiency virus‐exposed and unexposed infants admitted to a neonatal intensive care unit in Botswana (2014) (4)
Modulation of antigen expression on lymphoblastoid cell lines. (1981) (4)
IGA DEFICIENCY AND SALIVARY TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS (1986) (4)
Molecular characterization of hepatitis C virus in liver disease patients in Botswana: a retrospective cross-sectional study (2019) (4)
Rapid assessment of relationships among HIV isolates by oligopeptide analyses of external envelope glycoproteins. (1987) (4)
Isolation via transfection of feline leukemia viruses from DNA of naturally occurring feline lymphomas. (1981) (4)
Deep-sequence phylogenetics to quantify patterns of HIV transmission in the context of a universal testing and treatment trial – BCPP/ Ya Tsie trial (2021) (4)
AIDS in Asia (2004) (4)
Implementation of Universal HIV Testing and Treatment to Reduce HIV Incidence in Botswana: the Ya Tsie Study (2020) (4)
Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa (2016) (4)
Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa (2016) (4)
Antigenic characterization of the human immunodeficiency viruses. (1990) (4)
Introduction: The Etiology of AIDS (2002) (4)
Recruitment, Follow-Up and Characteristics of HIV Infected Adults who Use Illicit Drugs in Southern Africa. (2015) (4)
An Efficient Test for Comparing Sequence Diversity between Two Populations (2001) (3)
Botswana’s Progress Toward Achieving the 2020 UNAIDS 90– 90–90 Antiretroviral Treatment and Virologic Suppression Goals: Results of a Population-Based Survey (2016) (3)
FOCMA: A Transformation Specific RNA Sarcoma Virus Encoded Protein (1979) (3)
Africa and the biology of human immunodeficiency virus. (1987) (3)
Roundtable: can experience with veterinary retroviral vaccines be applied to the human situation? (1996) (3)
Absence of HTLV-I and HTLV-II infection in prostitutes in the area of seville, Spain (1991) (3)
The end of AIDS? (2017) (3)
Human immunodeficiency virus type 1 subtype E envelope recombinant peptides containing naturally immunogenic epitopes. (2000) (3)
UNUSUAL SEROLOGICAL PROFILES IN AIDS (1986) (3)
Gene therapy against retroviral diseases. (1995) (3)
Feline leukemia virus nonproducer lymphosarcomas of cats as a model for the etiology of human leukemias. (1981) (3)
Incidence of hepatitis B virus infection among human immunodeficiency virus-infected treatment naïve adults in Botswana (2020) (3)
Human Immunodeficiency Virus (HIV) Genetic Diversity Informs Stage of HIV-1 Infection Among Patients Receiving Antiretroviral Therapy in Botswana (2021) (3)
Virus: the Co-Discoverer of HIV Tracks Its Rampage and Charts the Future (2000) (3)
Evaluation of oral ribavirin therapy on immunologic and viral parameters in AIDS and ARC [abstract] (1986) (3)
Prevention of the contagious spread of the feline leukemia virus between pet cats. (1976) (3)
Pairwise diversity and tMRCA as potential markers for HIV infection recency (2017) (3)
Self-reported risky sexual practices among adolescents and young adults in Botswana (2019) (3)
Similar HIV protection from four weeks of zidovudine versus nevirapine prophylaxis among formula-fed infants in Botswana (2018) (3)
Human T-cell leukemia virus specific antigens. (1984) (3)
CCR 5 coreceptor utilization involves a highly conserved arginine residue of HIV type 1 gp 120 (1998) (3)
High incidence of tuberculosis in the first year of antiretroviral therapy in the Botswana National antiretroviral therapy programme between 2011 and 2015. (2019) (3)
Phylogenetic examination of HIV type 1 glycoprotein 120-V3 sequences in patients from rural Georgia. (1999) (2)
HIV/AIDS treatment in resource poor countries : (2013) (2)
Infection with feline leukemia virus associated with induction of humoral response to a normal cell protein. (1984) (2)
Relationship of simian T-lymphotropic virus type III to human retroviruses in Africa. (1987) (2)
The human immunodeficiency virus (HIV) as a newly evolving pathogen. (1997) (2)
CD101 genetic variants modify regulatory and conventional T cell phenotypes and functions (2021) (2)
Afri-Can Forum 2 (2016) (2)
Use of a mutation-specific genotyping method to assess for HIV-1 drug resistance in antiretroviral-naïve HIV-1 Subtype C-infected patients in Botswana. (2020) (2)
PANDAA intentionally violates conventional qPCR design to enable durable, mismatch-agnostic detection of highly polymorphic pathogens (2021) (2)
OA01-06 LB. HIV-1 plasma RNA and risk of HIV-1 transmission (2009) (2)
Correction: Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana (2018) (2)
[Presence of anti-HTLV (human T-cell leukemia virus) antibodies in blood donors from Martinique]. (1983) (2)
RAPID COMMUNICATION HIV-1 LTR Subtype and Perinatal Transmission (2001) (2)
FUNCTIONAL PRINCIPAL VARIANCE COMPONENT TESTING FOR A GENETIC ASSOCIATION STUDY OF HIV PROGRESSION. (2017) (2)
Afri-Can Forum 2 (2016) (2)
HIV-1 subtype C viruses rapidly develop K65R (2006) (2)
Immunosuppression by Moloney leukemia virus: lack of correlation between virus replication and the immunosuppressive effect. (1976) (2)
High HIV-1 RNA Among Newly Diagnosed People in Botswana. (2017) (2)
C-106 The Botswana Combination Prevention Project (BCPP): Addressing the UN 90-90-90 targets for 2020 (2016) (2)
Use of a mutation-specific genotyping method to assess for HIV-1 drug resistance in antiretroviral-naïve HIV-1 Subtype C-infected patients in Botswana (2021) (2)
Feline Leukemia and Immunological Surveillance (1979) (2)
Implications of HIV variability for transmission: scientific and policy issues. Expert Group of the Joint United Nations Programme on HIV/AIDS. (1997) (2)
Biochemical characterization of cells transformed via transfection by feline sarcoma virus proviral DNA (1981) (2)
Relative concordance of human immunodeficiency virus oligomeric and monomeric envelope in CCR5 coreceptor usage. (2008) (1)
Modulatory changes of HLA antigens during culture of lymphoblastoid cell lines (1980) (1)
Tumor immunology in domestic animals. (1979) (1)
Whole Genome Sequencing-based Characterization of Human Genome Variation and Mutation Burden in Botswana (2020) (1)
Transformation with subgenomic fragments of feline sarcoma virus proviral DNA. (1981) (1)
Comprar Emerging Infections in Asia | Roberts, Bryan | 9780387757216 | Springer (2008) (1)
High prevalence of chronic placental hypertensive damage, but no in utero HIV transmission, among women on HAART who deliver stillbirths in Botswana (2012) (1)
Are tuberculosis patients a 'sentinel' population for HIV epidemic in Africa? (1990) (1)
Feline leukemia virus : proceedings of the Third International Feline Leukemia Virus Meeting, St. Thomas, United States Virgin Islands, May 5-9, 1980 (1980) (1)
High Incidence of tuberculosis in the first year of antiretroviral therapy in the Botswana National ART programme between 2011 and 2015. (2019) (1)
Host Immune Response to Oncornavirus-Induced Tumors1 (1976) (1)
Correction: Genomewide Association Study for Determinants of HIV-1 Acquisition and Viral Set Point in HIV-1 Serodiscordant Couples with Quantified Virus Exposure (2012) (1)
Population uptake of HIV testing, treatment, viral suppression, and male circumcision in Botswana: a cluster-randomized trial (2021) (1)
Undetectable proviral deoxyribonucleic acid in an adolescent perinatally infected with human immunodeficiency virus-1C and on long-term antiretroviral therapy resulted in viral rebound following antiretroviral therapy termination (2019) (1)
Track C Epidemiology and Prevention Science (2012) (1)
Host immune response to oncornavirus-induced tumors. (1975) (1)
Short communication: effect of short-course antenatal zidovudine and single-dose nevirapine on the BED capture enzyme immunoassay levels in HIV type 1 subtype C infection. (2013) (1)
Genome-wide association study reveals genetic variants associated with HIV-1C infection in a Botswana study population (2021) (1)
Detection of inducible replication-competent HIV-1C provirus despite long-term antiretroviral treatment in perinatally infected adolescents in Botswana. (2020) (1)
Chemoprophylaxis and HAART Therapy in Botswana (2005) (1)
Pathobiology of human T-cell leukemia virus. (1985) (1)
HPTN 069/ACTG A5305: phase II study of maraviroc-containing regimens for HIV PrEP in US women; Postive impact of a randomized controlled trial of the Uthando Lwethu ("Our Love") intervention on rates of couples HIV testing in rural South Africa (2016) (1)
[The HTL IV virus: a new human retrovirus without pathogen protection against the HTLV III/LAV virus?]. (1986) (1)
Analysis of HIV-1 gp120 quasispecies suggests high prevalence of intra-subtype recombination (2012) (0)
Conclusion/perspective I--National Cancer Institute Workshop on the emerging epidemic of non-Hodgkin's lymphoma: current knowledge regarding etiological factors. (1992) (0)
Mutational Analysis ofConserved N-LinkedGlycosylation Sitesof HumanImmunodeficiency VirusType1gp4l (1992) (0)
Evolutionary dynamics of HIV-1 subtype C accessory and regulatory genes in primary infection (2012) (0)
Letter from Max Essex, Harvard School of Public Health to Harold Varmus (1985) (0)
O15.1 Sub-Optimal CD4 T-Cell Recovery in HIV-1 Subtype C Patients on Antiretroviral Therapy: A Search For Predictive Biomarkers and Baseline Characteristics (2013) (0)
HIV HTLV-1 and HBV Infection in Pregnant Women From an Urban Population in Zaire (1989) (0)
Clones from Botswana Type 1 Subtype C: a Set of 23 Full-Length Virus Analysis of Human Immunodeficiency Molecular Cloning and Phylogenetic (2013) (0)
Antibody Response Pattern and Prediction of Perinatal Transmission of HIV-1 in African Women. The Congolese Research Group on Mother-to-Child Transmission of HIV (1993) (0)
Track B Clinical Science (2012) (0)
TUPDC0103: Gonorrhea infections diagnosed among persons living with HIV: cross matching surveillance registries to identify potential opportunities for integrated partner services-New York City, Washington D.C., Miami/Dade County and Arizona (2012) (0)
Maternal or infant antiretroviral drugs to reduce HIV-1 transmission (2010) (0)
Transfusion-acquired HIV infection among immunocompromised hosts. (1987) (0)
HIV-1 drug resistance mutations among individuals with low-level viraemia while taking combination ART in Botswana. (2022) (0)
Ethics of placebo-controlled trials of zidovudine to prevent the perinatal transmission of HIV in the Third World. (1998) (0)
OpenReading FramevprofSimian Immunodeficiency Virus Encodes aVirion-Associate d Protein (1990) (0)
Mutations intheCytoplasmic DomainofHuman Immunodeficiency VirusType1Transmembrane Protein Impair theIncorporation ofEnvProteins intoMatureVirions (1993) (0)
HIV-1 drug mutations in children from northern Tanzania made this article openly available. Please share how this access benefits you. Your story matters (2014) (0)
Abstracts of the Eighth EDCTP Forum, 6–9 November 2016 (2017) (0)
Epidemiology of HIV-2 in Female Prostitutes in Senegal (1989) (0)
Biology of Human T Cell Leukemia Viruses in Immunosuppression and AIDS (1985) (0)
Analyse de detection d'une infection par un virus lymphotrophique de cellules t humaines (1985) (0)
Evolution of the Leukemic State Group Report (1985) (0)
A simple method for quantitating salivary levels of virus using calcium alginate swabs. (1979) (0)
Doravirine-associated resistance mutations in antiretroviral therapy naïve and experienced adults with HIV-1 subtype C infection in Botswana (2022) (0)
Design ? Consensus Sequence for an AIDS Vaccine Subtype C Molecular Phylogeny : Human Immunodeficiency Virus Type 1 (2002) (0)
The N-terminal region of the human immunodeficiency virus envelope glycoprotein gpl 20 contains potential binding sites for CD 4 WAN-JR SYU (0)
Molecular characterization of hepatitis B virus in blood donors in Botswana (2015) (0)
Virology (2007) (0)
From Biology to Policy (2015) (0)
Plasma Cytokine Levels in Chronic Asymptomatic HIV-1 Subtype C Infection as an Indicator of Disease Progression in Botswana: A Retrospective Case Control Study. (2016) (0)
Retrovirus transformation associated secretory phosphoproteins of mouse and mink cells. (1992) (0)
Correction for Novitsky et al., Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering (2016) (0)
High Prevalence of Hepatitis B Virus Infection Among People With HIV in Rural and Periurban Communities in Botswana (2023) (0)
Detection of low frequency drug resistant mutations in antiretroviral-treated HIV-1C infections (2006) (0)
Fifth International Conference on AIDS : the Scientific and Social Challenge; symposium; origins of human retroviruses and animal modules (1989) (0)
The role of CYP2B6 516G>T polymorphism on efavirenz/nevirapine toxicity. Implications on treatment outcomes (2022) (0)
Inferring HIV-1 transmission networks and sources of epidemic spread in Africa with deep-sequence phylogenetic analysis (2019) (0)
Analysis of HIV-1 gp120 quasispecies suggests high prevalence of intra-subtype recombination (2012) (0)
Evolutionary dynamics of HIV-1 subtype C accessory and regulatory genes in primary infection (2012) (0)
[Trials of anti-HIV vaccines on newborns?] (1997) (0)
Procedes therapeutiques destines au sida, a base de peptides vpx d'hiv-2 (1993) (0)
Protein Primarily against the Adenovirus Hexon Serotype 5 Vaccine Vectors Are Directed Neutralizing Antibodies to Adenovirus (2005) (0)
Antibody in African Sera (0)
Selection of subcohorts. (2014) (0)
Virus t-lymphotrophique (1986) (0)
Simpliﬁed Strategy for Detection of Recombinant Human Immunodeﬁciency Virus Type 1 Group M Isolates by gag/env Heteroduplex Mobility Assay OF HIV EPIDEMICS IN AFRICAN (1999) (0)
140 Reversing the Epidemic of HIV-1C in Southern Africa with Treatment as Prevention (2014) (0)
A1 Pairwise diversity and tMRCA as potential markers of HIV infection recency (2018) (0)
Risks and predictors of perinatal transmission of HIV-1. (1994) (0)
AZT trials to reduce perinatal HIV transmission: a debate about science ethics and resources. Roundtable. Letter to the editor of the NEJM. (1998) (0)
Feline leukemia in Israel: prevalence of antibody to feline oncornavirus-associated cell membrane antigen in stray cats. (1980) (0)
P023: Studies on the mechanism of hepatitis B virus cccDNA inhibition by adenovirus early proteins (2015) (0)
Localization ofImmunogenic DomainsintheHuman Immunodeficiency Virus Type2Envelope (1991) (0)
Immunosuppression by Human and Feline Retroviruses (1986) (0)
Whole Genome Rare-Variant Association Study of HIV-1 Progression in a Southern African Population (2020) (0)
Prediction of Coreceptor Tropism in HIV-1 Subtype C in Botswana (2023) (0)
Role of viruses in the etiology of naturally occurring feline leukemia. (1981) (0)
Epidemiological and viral characteristics of undiagnosed HIV infections in Botswana (2022) (0)
LOW FALSE RECENT RATE OF LIMITING ANTIGEN AVIDITY ASSAY COMBINED WITH HIV-1 RNA DATA IN BOTSWANA (2017) (0)
The Preleukemic State in Virus-induced Leukemia (1985) (0)
An assay method for detection of human lymphotropischem virus. (1985) (0)
Prevention of HIV Infection in the Absence of a Vaccine (2013) (0)
HIV/AIDS: Lessons from a New Disease Pandemic (2008) (0)
Proposal forNamingHostCell-Derived Inserts inRetrovirus Genomest (1981) (0)
GLYCOLYSIS DURING FeLV INFECTION RESULTS Infection of cells by FeLV . Inoculation of either (0)
Test method for evidence of human lymphotropischem virus. (1985) (0)
Noma in children with immunodeficiency severe combined (1986) (0)
Overweight in early HIV predicts slower disease progression in HIV+ Adults in Botswana (2012) (0)
[Distribution of antibodies against the human T-cell leukemia virus in healthy Venezuelan adults]. (1985) (0)
PANDAA intentionally violates conventional qPCR design to enable durable, mismatch-agnostic detection of highly polymorphic pathogens (2021) (0)
Prevalence and molecular characterization of Hepatitis B in HIV infected individuals in Botswana (2014) (0)
Immune response to tumor cells in domestic animals. (1982) (0)
Changes in inflammatory marker concentrations between the third trimester and six months postpartum. (2014) (0)
Recombinants and the future of the epidemic. A roundtable discussion. (2001) (0)
Feline leukemia virus-and feline sarcoma virus-related polypeptides released by virus producer and nonproducer cells. (1985) (0)
Tumor Antigens and Transformation-Related Proteins Associated with Feline Retroviruses (1983) (0)
Comparative research in leukemia and related diseases. An introduction to a scientific approach (1999) (0)
Transmissibility of animal cancer viruses. (1977) (0)
Nonrandom distribution of gpl 20 N-linked glycosylation sites important for infectivity of human immunodeficiency virus type 1 ( envelope glycoprotein / vaccine development ) (0)
HTLV-1 INFECTION IN ASYMTOMATIC INDIVIDUALS AND PATIENTS IN NIGERIA (1996) (0)
Detection and localization of a phosphotyrosine-containing onc gene product in feline tumor cells. (1983) (0)
The hunt for the AIDS vaccine. (1995) (0)
Origins of HTLV-III (HIV). (1987) (0)
Neoplasms of cats caused by oncornaviruses. (1975) (0)
CTL Diverse Viral Subtypes by Vaccine-Induced Recognition of Variant HIV-1 Epitopes from and (2004) (0)
Thevpx GeneofSimianImmunodeficiency VirusFacilitates Efficient Viral Replication inFreshLymphocytes andMacrophages (1991) (0)
Human T-cell leukemia virus-associated nuclear antigen (HTLV-NA). (1986) (0)
Africa and the origin of AIDS. (1985) (0)
P20-12. Heterogeneity of Gag mutational pathways in primary HIV-1 subtype C infection (2009) (0)
Pathobiology of simian T-lymphotropic virus type III [abstract] (1986) (0)
Introduction I—National Cancer Institute Workshop on the Emerging Epidemic of Non-Hodgkin's Lymphoma: Current Knowledge Regarding Etiological Factors (1992) (0)
Human T-cell leukemia virus-associated membrane antigens : Identity of the major antigens recognized after virus infection ( human T-cell leukemia virus / gp 6 l / membrane immunofluorescence / radiosequence analysis ) (0)
Sub-Optimal CD4 t-Cell ReCOveRy in Hiv-1 Subtype C patientS On antiRetROviRal tHeRapy: a SeaRCH FOR pReDiCtive biOmaRkeRS anD baSeline CHaRaCteRiStiCS (2013) (0)
Methods and products for the detection of human t-cell leukemia virus. (1984) (0)
Association of CYP2B6 Genetic Variation with Efavirenz and Nevirapine Drug Resistance in HIV-1 Patients from Botswana [Corrigendum] (2021) (0)
Mutations intheN-Terminal RegionofHuman Immunodeficiency VirusType1Matrix Protein Block Intracellular Transport oftheGagPrecursor (1993) (0)
Pattern of gpl20 sequence divergence linked to a lack of clinical progression in human immunodeficiency virus type 1 infection (2005) (0)
22nd International BioInformatics Workshop on Virus Evolution and Molecular Epidemiology (2018) (0)
Health impact and cost-effectiveness of HIV testing, linkage, and early antiretroviral treatment in the Botswana Combination Prevention Project (2022) (0)
Cross-reactivity tohumanT-lymphotropic virus typeIII/ lymphadenopathy-associated virus andmolecular cloning ofsimian T-cell lymphotropic virus typeIIIfromAfrican greenmonkeys (1986) (0)
Comparative research on leukemia and related diseases: An introduction to a scientific approach (1997) (0)
P2.49 Prevalence and molecular characterisation of hepatitis b virus in blood donors in botswana (2017) (0)
Retroviruses: leukemia and immunosuppression. The Yohei Ito memorial lecture. (1988) (0)
A presentation at a UNAIDS research meeting. (2001) (0)
108 HIV-1C of Southern Africa: Why Is the Virus More Fit? (2011) (0)
Genetic variation in HIV-1C: implications for prevention and treatment (2006) (0)
HIV-1C in-House RNA-Based Genotyping Assay for Detection of Drug Resistance Mutations in Samples with Low-Level Viral Loads (2022) (0)
The family of T-lymphotropic viruses in primates and humans [abstract] (1986) (0)
Immunology of HIV (1989) (0)
Universal Testing and Treatment for HIV Infection in Botswana. Reply. (2019) (0)
Sound policy, not AIDS hysteria. (1991) (0)
Conserved determinants of enhanced CCR5 binding in the human immunodeficiency virus subtype D envelope third variable loop. (2010) (0)

This paper list is powered by the following services:

Other Resources About Max Essex

en.wikipedia.org

What Schools Are Affiliated With Max Essex?

Max Essex is affiliated with the following schools:

Image Attributions

Image Source for Max Essex